PMC:7264098 / 23180-23321 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T332","span":{"begin":66,"end":76},"obj":"SP_7"},{"id":"T333","span":{"begin":96,"end":100},"obj":"DG_47"},{"id":"T66586","span":{"begin":66,"end":76},"obj":"SP_7"},{"id":"T50773","span":{"begin":96,"end":100},"obj":"DG_47"}],"text":"In the majority of clinical trials investigating the treatment of SARS-CoV-2 infections so far, MSCs are delivered via the intravenous route."}

{"project":"LitCovid-PubTator","denotations":[{"id":"456","span":{"begin":66,"end":87},"obj":"Disease"}],"attributes":[{"id":"A456","pred":"tao:has_database_id","subj":"456","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In the majority of clinical trials investigating the treatment of SARS-CoV-2 infections so far, MSCs are delivered via the intravenous route."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T141","span":{"begin":66,"end":74},"obj":"Disease"},{"id":"T142","span":{"begin":66,"end":70},"obj":"Disease"},{"id":"T143","span":{"begin":77,"end":87},"obj":"Disease"}],"attributes":[{"id":"A141","pred":"mondo_id","subj":"T141","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A142","pred":"mondo_id","subj":"T142","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A143","pred":"mondo_id","subj":"T143","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"In the majority of clinical trials investigating the treatment of SARS-CoV-2 infections so far, MSCs are delivered via the intravenous route."}

{"project":"LitCovid-sentences","denotations":[{"id":"T136","span":{"begin":0,"end":141},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In the majority of clinical trials investigating the treatment of SARS-CoV-2 infections so far, MSCs are delivered via the intravenous route."}